Department of Pulmonology and Allergology, North University Hospital, Marseille, France.
Respiration. 2012;83(5):418-20. doi: 10.1159/000334312. Epub 2011 Dec 21.
Bronchoscopic lung volume reduction using endobronchial valves has been suggested as a potentially safer alternative to surgery in selected cases. Complications of this technique include pneumothoraces, pneumonia, COPD exacerbations, hemoptysis, and valve migrations. We report the case of a male patient who developed a parenchymal mass in the treated lobe after valve insertion. Due to severe emphysema, transthoracic needle aspiration was not feasible. Removal of the valves was mandatory to perform transbronchialbiopsies which revealed a non-small cell primary lung cancer. This first description illustrates the potential risk of lung cancer development following bronchoscopic lung volume reduction and highlights the different approach to diagnosis and management of indeterminate peripheral lung lesions needed in this context.
经支气管镜肺减容术使用支气管内瓣膜已被建议作为一种有选择的手术替代方法,用于特定病例。该技术的并发症包括气胸、肺炎、COPD 恶化、咯血和瓣膜移位。我们报告了一例患者,在瓣膜插入后治疗的肺叶中出现实质性肿块。由于严重肺气肿,经胸针刺抽吸不可行。必须移除瓣膜以进行经支气管活检,活检显示非小细胞原发性肺癌。这是首例描述,说明了支气管镜肺减容术后肺癌发展的潜在风险,并强调了在这种情况下需要对不确定的周围性肺病变进行诊断和管理的不同方法。